The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer

International Journal of Colorectal Disease

Volumn 28, Issue 12, 2013, Pages 1629-1636

  Azab, Basem ^a   Kedia, Shiksha ^a   Shah, Neeraj ^a   Vonfrolio, Steven ^a   Lu, William ^a   Naboush, Ali ^a   Mohammed, Farhan ^a   Bloom, Scott W ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

Albumin globulin ratio; Colorectal cancer; Mortality

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; GLOBULIN;

AGED; AGR TERTILE; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CHEMICAL PARAMETERS; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DATA BASE; FEMALE; GLOBULIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE VALUE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

AGED; COLORECTAL NEOPLASMS; FEMALE; GLOBULINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; SERUM ALBUMIN;

EID: 84889881428     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1748-z     Document Type: Article

References (35)

1. American Cancer Society (2011) Colorectal cancer facts & figures 2011-2013. American Cancer Society, Atlanta
2. Betge J, Pollheimer MJ, Lindtner RA et al (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118(3):628-638
3. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28(2):264-271
4. Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14(7):1074-1080
5. Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10(1):65-71
6. Wohlke M, Schiffmann L, Prall F (2011) Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-up. Histopathology 59(5):857-866
7. Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M (2011) Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2(1):95-101
8. Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6(1):149-163
9. Inoue Y, Iwata T, Okugawa Y et al (2013) Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology 84(2):100-107
10. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073-1081
11. McPherson R, Pincus MR (2011) Henry's clinical diagnosis and management by laboratory methods, 22nd edn. Saunders, Philadelphia
12. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448-454
13. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39(2):210-213
14. Fearon KC, Falconer JS, Slater C, McMillan DC, Ross JA, Preston T (1998) Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg 227(2):249-254
15. Andersson C, Lonnroth C, Moldawer LL, Ternell M, Lundholm K (1990) Increased degradation of albumin in cancer is not due to conformational or chemical modifications in the albumin molecule. J Surg Res 49(1):23-29
16. Lai CC, You JF, Yeh CY et al (2011) Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Color Dis 26(4):473-481
17. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22(8):881-886
18. Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69
19. Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A (2006) Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit 12(6):CR240-CR247
20. Dixon MR, Haukoos JS, Udani SM et al (2003) Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 138(9):962-966
21. Heys SD, Walker LG, Deehan DJ, Eremin OE (1998) Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43(3):163-168
22. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6):1047-1051
23. Kaysen GA (2001) The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol: JASN 12(7):1549-1557
24. Kaysen GA (2003) Serum albumin concentration in dialysis patients: why does it remain resistant to therapy? Kidney Int Suppl 87:S92-S98
25. Sonnenschein C, Soto AM, Michaelson CL (1996) Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol 59(2):147-154
26. Laursen I, Briand P, Lykkesfeldt AE (1990) Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res 10(2A):343-351
27. Cohen MH, Makuch R, Johnston-Early A et al (1981) Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep 65(3-4):187-195
28. Codina Cazador A, Salva Lacombe JA, Fernandez-Llamazares Rodriguez J, Ruiz Feliu B, Codina Barreras A, Moreno Aguado V (1989) Immunoglobulins and the complement system in colorectal cancer. Rev Esp Enferm Apar Dig 75(2):143-148
29. Oner F, Savas I, Numanoglu N (2004) Immunoglobulins and complement components in patients with lung cancer. Tuberk Toraks 52(1):19-23
30. Shimada H, Nabeya Y, Okazumi S et al (2003) Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 83(4):248-252
31. Gerhardt T, Milz S, Schepke M et al (2006) C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol 12(34):5495-5500
32. Canna K, McArdle PA, McMillan DC et al (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92(4):651-654
33. Osman W, Okada Y, Kamatani Y, Kubo M, Matsuda K, Nakamura Y (2012) Association of common variants in TNFRSF13B, TNFSF13, and ANXA3 with serum levels of non-albumin protein and immunoglobulin isotypes in Japanese. PLoS One 7(4):e32683
34. Al-Joudi FS (2005) Prognostic value of an index for serum globulin compensation in colon and breast cancers. Singap Med J 46(12):710-713
35. Hong KW, Jin HS, Song D, Kwak HK, Soo Kim S, Kim Y (2013) Genome-wide association study of serum albumin:globulin ratio in Korean populations. J Hum Genet 58(3):174-177